Innovative Advances in Protein Design and Plant-Based Medicines
Written on
Chapter 1: Revolutionizing Drug Production
The field of synthetic biology is witnessing remarkable breakthroughs, particularly in the production of plant-based pharmaceuticals using engineered organisms. Notably, researchers at Stanford University, Prashanth Srinivasan and Christina Smolke, have developed a method to enable baker's yeast to synthesize tropane alkaloids. These compounds, typically derived from nightshade and used for treating neuromuscular issues, are now created using basic sugars and amino acids. The construction of this synthetic pathway necessitated the coordination of over twenty different proteins sourced from yeast, bacteria, plants, and animals, which were strategically directed to six sub-cellular compartments to facilitate medicine production. This significant study has garnered attention, being featured in Nature and various media outlets, including a Stanford press release.
Video Description: David Baker discusses the application of deep learning in protein design, emphasizing innovative techniques.
Section 1.1: Enhanced DNA Assembly Techniques
In a groundbreaking paper published in 2018, researchers from New England Biolabs and Ginkgo Bioworks introduced an enhanced method for Golden Gate DNA assembly, which allowed for the accurate combination of 24 DNA fragments in a single tube. Building on this earlier work, the same authors have now reported the routine assembly of 35 DNA fragments within a single reaction. They optimized their approach through DNA sequencing, exploring various combinations of restriction enzymes, which led to the development of a suite of web tools aimed at improving DNA assembly efficiency. This study appeared in PLoS One.
Section 1.2: Self-Building Minicells
A fascinating study published in Nature Communications investigates the possibility of constructing a cell from the ground up. Researchers demonstrated that liposomes—essentially phospholipid sacs filled with water—can be loaded and programmed with a genetic blueprint. These liposomes were infused with a loop of DNA that encoded seven different genes, forming a biosynthetic pathway for producing phospholipids. By utilizing fluorescence-based probes, the scientists were able to visualize the incorporation of synthesized phospholipids at the level of individual vesicles, effectively showcasing that miniature cells can autonomously construct themselves.
Video Description: This video explores the role of deep learning in structural biology and protein design, examining its implications and methodologies.
Chapter 2: Precision in Gene Regulation
Section 2.1: Optimizing Gene Expression in Plants
Promoters, which are short DNA sequences located upstream of genes, play a critical role in regulating protein production levels. However, deciphering the intricate rules governing promoter functionality has been challenging. Recently, the Patron lab presented an experimental framework that systematically studies how various traits of promoters, such as their sequence and the arrangement of regulatory elements, influence gene expression. The results led to the creation of a series of "minimal" promoters designed for precise tuning of gene output, as reported in Nucleic Acids Research.
Section 2.2: Standardizing Measurements in Synthetic Biology
The International Genetically Engineered Machine competition (iGEM) has fostered collaboration among young synthetic biologists for nearly two decades, particularly through its measurement labs where students gauge engineered cells. A recent study in ACS Synthetic Biology addresses the pressing need for measurement standardization in synthetic biology. Researchers have introduced a software tool developed in R, designed to calibrate fluorescent and plate reader measurements, promoting consistency across laboratories.
Chapter 3: Summary of Recent Innovations
This week's highlights in synthetic biology include significant advancements such as the improved MAGE method for genome editing, CRISPR applications in yeast, and explorations into the potential of anti-CRISPR proteins for gene circuit construction. The Church lab's utilization of machine learning for guiding protein engineering also stands out, suggesting that a mere 24 functionally tested mutant sequences can create a precise virtual fitness landscape. These innovations underline the rapid progress being made in the realm of synthetic biology.
Thanks for engaging with this overview of significant developments in synthetic biology. For more insights and discussions, feel free to connect via Twitter @NikoMcCarty or visit bioeconomy.xyz.